Evidence map›Paper›PMID 27990180›Full record

ArticleCellular and molecular bioengineering2016

The effect of RGD peptide on 2D and miniaturized 3D culture of HEPM cells, MSCs, and ADSCs with alginate hydrogel.

Jenna Dumbleton, Pranay Agarwal, Haishui Huang, Nathaniel Hogrebe, Renzhi Han, Keith J Gooch, Xiaoming He

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular bioengineering, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Bioencapsulation technologies in tissue engineering.Journal of applied biomaterials & functional materials · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jenna DumbletonDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA).
Pranay AgarwalDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA).
Haishui HuangDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA); Department of Mechanical and Aerospace Engineering, The Ohio State University, Columbus, OH 43210 (USA).
Nathaniel HogrebeDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA).
Renzhi HanDorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA); Department of Surgery, The Ohio State University, Columbus, OH 43210 (USA).
Keith J GoochDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA).
Xiaoming HeDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA); Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA); Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210 (USA).
The Ohio State University · USLung Institute · US

Funding

Microfluidic encapsulation of ovarian follicles for biomimetic 3D culture andcryopreservationR01EB023632 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI HE, XIAOMING · 2017 to 2020
$1.6M
Microencapsulation of oocytes for low-CPA (cryoprotectant) vitrificationR01EB012108 · NIBIB · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HE, XIAOMING · 2011 to 2014
$1.3M
NIBIB NIH HHS R01 EB012108NIBIB NIH HHS R01 EB023632
6 · The paper itself

Abstract

Advancements in tissue engineering require the development of new technologies to study cell behavior

Indexed as

3D culturebiomimeticCore-shell microcapsulesstem cell

Identifiers

PMID27990180
PMCPMC5157694
OpenAlexW2276226741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.